Potassium news

All news on Potassium: plants, production capacities, investments and involved companies.

12 December 2025

FDA Approves Johnson & Johnson's AKEEGA for BRCA2-Mutated Prostate Cancer

FDA approves AKEEGA for BRCA2-mutated prostate cancer, reducing disease progression by 54% and delaying symptoms by 59% in clinical trials.

Who will be producing Potassium in the future?

Find out with chemXplore Analytics